Point72 Middle East FZE »

Seres Therapeutics shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $55k 39k 1.40
2022-12-31 $61k 11k 5.60

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Seres Therapeutics

Flagship Ventures Management
Vanguard Group
Hudson Bay Capital Management
Bank of America Corporation
Millennium Management
Point72 Asset Management
Tang Capital Management
Handelsbanken Fonder AB
Charles Schwab Investment Management
Goldman Sachs Group
Advisor Group Holdings
Hrt Financial
T. Rowe Price Associates
Two Sigma Investments
Lion Point Capital

View all funds holding Seres Therapeutics